Trial Details

COMPLETED
Basic Information
Clinical ID c2982
Identifier NCT02694588
Trial Title Clinical and Molecular Phenotyping in IBD
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions IBD
Interventions DRUG: Infliximab|DRUG: Vedolizumab
Participant Information
Sponsor University Hospital Schleswig-Holstein
City Kiel
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2014-06
Primary Completion Date 2018-10
Completion Date 2021-12